APA

Savard C., Laliberté-Gagné M., Babin C., Bolduc M., Guérin A., Drouin K., Forget M., Majeau N., Lapointe R. & Leclerc D. (20120709). Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. : Vaccine.

Chicago

Savard Christian, Laliberté-Gagné Marie-Ève, Babin Cindy, Bolduc Marilène, Guérin Annie, Drouin Karine, Forget Marie-Andrée, Majeau Nathalie, Lapointe Réjean and Leclerc Denis. 20120709. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. : Vaccine.

Harvard

Savard C., Laliberté-Gagné M., Babin C., Bolduc M., Guérin A., Drouin K., Forget M., Majeau N., Lapointe R. and Leclerc D. (20120709). Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. : Vaccine.

MLA

Savard Christian, Laliberté-Gagné Marie-Ève, Babin Cindy, Bolduc Marilène, Guérin Annie, Drouin Karine, Forget Marie-Andrée, Majeau Nathalie, Lapointe Réjean and Leclerc Denis. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. : Vaccine. 20120709.